Exosomal microRNA as biomarkers | Biofluid | Clinical significance | References |
---|---|---|---|
exo-miR-215-5p | Serum | Overexpression predicts poor disease-free survival in patients with HCC | [117] |
miR-10b-5p | Serum | Potential biomarker for early-stage HCC | [117] |
miR-18a, miR-221, miR-222, miR-224, miR-101, miR-106b, miR-122, miR195 | Serum | Novel serological biomarkers for HCC | [43] |
miR-122, miR-148a and AFP | Serum | Distinguish early HCC from liver cirrhosis | [41] |
miR-122 | Serum | Distinguish HCC from normal control | [41] |
miR-9-3p | Serum | A therapeutic target for HCC | [69] |
miR-665 | Serum | A novel minimally invasive biomarker for HCC diagnosis and prognosis | [70] |
miR-21 | Serum | A potential biomarker for HCC diagnosis. | [40] |